We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
NextDecade
NEXT
$1.84B
| $183K | ﹤0.01% |
+41,252
| New | +$256K |
|
2952
USCB Financial Holdings
USCB
$409M
| $183K | ﹤0.01% |
+15,892
| New | +$210K |
|
|
SCWX
2953
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $183K | ﹤0.01% |
16,869
+1,780
| +12% | +$20.2K |
|
|
RBOT
2954
DELISTED
Vicarious Surgical
RBOT
| $182K | ﹤0.01% |
+2,061
| New | +$252K |
|
2955
Blue Bird Corp
BLBD
$2.16B
| $181K | ﹤0.01% |
19,679
+518
| +3% | +$7.26K |
|
2956
Lexicon Pharmaceuticals
LXRX
$1.04B
| $181K | ﹤0.01% |
97,470
+17,536
| +22% | +$33.5K |
|
2957
The ONE Group
STKS
$54.3M
| $181K | ﹤0.01% |
24,561
+9,972
| +68% | +$91K |
|
|
CISO
2958
CISO Global
CISO
$11.7M
| $180K | ﹤0.01% |
+3,325
| New | +$258K |
|
2959
Precigen
PGEN
$2.54B
| $179K | ﹤0.01% |
133,547
+35,002
| +36% | +$51.9K |
|
2960
Sweetgreen
SG
$638M
| $179K | ﹤0.01% |
15,343
+4,822
| +46% | +$102K |
|
2961
1stdibs.com
DIBS
$173M
| $178K | ﹤0.01% |
31,264
+16,396
| +110% | +$108K |
|
2962
RenaissanceRe Holdings 4.20% Series G Preference Share
RNR.PRG
$302M
| $178K | ﹤0.01% |
+10,000
| New | +$187K |
|
2963
The Beachbody Company
BODI
$74.7M
| $178K | ﹤0.01% |
+2,969
| New | +$241K |
|
|
ICVX
2964
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $177K | ﹤0.01% |
30,831
+10,469
| +51% | +$81.7K |
|
2965
Nautilus Biotechnolgy
NAUT
$110M
| $175K | ﹤0.01% |
+65,231
| New | +$243K |
|
2966
Pioneer Bancorp
PBFS
$435M
| $174K | ﹤0.01% |
+17,801
| New | +$180K |
|
|
ALPN
2967
DELISTED
Alpine Immune Sciences Inc
ALPN
| $174K | ﹤0.01% |
+20,404
| New | +$176K |
|
|
JNCE
2968
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $174K | ﹤0.01% |
57,441
+14,406
| +33% | +$70.1K |
|
2969
Offerpad Solutions
OPAD
$24.2M
| $170K | ﹤0.01% |
+521
| New | +$350K |
|
|
PZN
2970
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $170K | ﹤0.01% |
25,747
+4,847
| +23% | +$33K |
|
|
KLRS
2971
Kalaris Therapeutics
KLRS
$97.5M
| $169K | ﹤0.01% |
1,888
+640
| +51% | +$67.1K |
|
2972
Duluth Holdings
DLTH
$157M
| $168K | ﹤0.01% |
17,656
+6,533
| +59% | +$76K |
|
|
IRNT
2973
DELISTED
IronNet, Inc.
IRNT
| $168K | ﹤0.01% |
+75,997
| New | +$215K |
|
2974
Legacy Housing
LEGH
$699M
| $167K | ﹤0.01% |
+12,790
| New | +$216K |
|
2975
Quad
QUAD
$517M
| $166K | ﹤0.01% |
+60,380
| New | +$292K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.